# Allogene Therapeutics, Inc. (ALLO)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ALLO/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 4.64M | $ -85.28M | $ -45.07M | $ 70.35M | $ 436.18M |
| 2025 | $ 0 | $ -195.45M | $ -153.21M | $ 83.25M | $ 292.54M |
| 2024 | $ 23.1K | $ -270.75M | $ -211.26M | $ 90.76M | $ 422.18M |
| 2023 | $ 32.4K | $ -357.62M | $ -258.69M | $ 95.12M | $ 512.23M |
| 2022 | $ 271.5K | $ -371.59M | $ -252.14M | $ 101.12M | $ 666.88M |
| 2021 | $ 45.75M | $ -305.49M | $ -245.17M | $ 73.13M | $ 925.20M |
| 2020 | $ 0 | $ -318.76M | $ -230.65M | $ 53.78M | $ 1.08B |
| 2019 | $ 0 | $ -238.26M | $ -242.84M | $ 53.03M | $ 629.02M |
| 2018 | $ 0 | $ -279.33M | $ -63.24M | $ 34.46M | $ 703.16M |
| 2017 | $ 0 | $ -2.7K | $ 0 | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.16 |
| Liabilities / Eq | 0.26 |
| Current Ratio | 10.72 |

## Other views

- [Metrics](https://sponda.capital/en/ALLO.md)
- [Charts](https://sponda.capital/en/ALLO/charts.md)
- [Compare](https://sponda.capital/en/ALLO/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.